FDA: Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV

79

The FDA has approved Cabenuva, an injectable once-a-month therapeutic for HIV-1. For some HIV patients, this could mean a substantial improvement over taking daily pills. The treatment is intended for adults who are virologically suppressed and have no history of treatment failure or resistance to cabotegravir or rilpivirine. Click here to read more from the FDA, and here to read about COVID-19.

Comments are closed.

Skip to toolbar